Literature DB >> 8696919

Analysis of immunosuppressive activity of serial dilutions of histamine on human basophil activation by flow cytometry.

J Sainte-Laudy1, P Belon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8696919     DOI: 10.1007/bf03354076

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  5 in total

1.  Intracellular events in anti-IgE nonreleasing human basophils.

Authors:  E F Knol; F P Mul; T W Kuijpers; A J Verhoeven; D Roos
Journal:  J Allergy Clin Immunol       Date:  1992-07       Impact factor: 10.793

2.  Monitoring human basophil activation via CD63 monoclonal antibody 435.

Authors:  E F Knol; F P Mul; H Jansen; J Calafat; D Roos
Journal:  J Allergy Clin Immunol       Date:  1991-09       Impact factor: 10.793

3.  Flow cytometric evaluation of human basophils.

Authors:  P Gane; C Pecquet; P Lambin; N Abuaf; F Leynadier; P Rouger
Journal:  Cytometry       Date:  1993

4.  Human basophil degranulation triggered by very dilute antiserum against IgE.

Authors:  E Davenas; F Beauvais; J Amara; M Oberbaum; B Robinzon; A Miadonna; A Tedeschi; B Pomeranz; P Fortner; P Belon
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

5.  [Analysis of membrane expression of the CD63 human basophil activation marker. Applications to allergologic diagnosis].

Authors:  J Sainte-Laudy; C Vallon; J C Guérin
Journal:  Allerg Immunol (Paris)       Date:  1994-06
  5 in total
  2 in total

1.  Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study.

Authors:  Salvatore Chirumbolo; Maurizio Brizzi; Riccardo Ortolani; Antonio Vella; Paolo Bellavite
Journal:  Inflamm Res       Date:  2009-05-06       Impact factor: 4.575

2.  Immunology and homeopathy. 2. Cells of the immune system and inflammation.

Authors:  Paolo Bellavite; Anita Conforti; Francesco Pontarollo; Riccardo Ortolani
Journal:  Evid Based Complement Alternat Med       Date:  2006-02-05       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.